Possible online services disruption due to Internet related outage
Drugs and Therapeutics Committee Meeting Results Meeting Results for: December 12, 2007
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Altabax | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Avinza | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Azor | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Byetta | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Cerefolin NAC | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Depakote ER | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Exforge | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Invega | New Drug Initial Review | Remove Prior Approval Requirement | Prior Approval requirement removed |
Istalol | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Lantus | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Natelle | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Neupro | New Drug Initial Review | Remove Prior Approval Requirement | Prior Approval requirement removed |
Perforomist | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Pylera | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Veramyst | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Xibrom | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Xyzal | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Zinotic | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Zyflo CR | New Drug Initial Review | Require Prior Approval | Prior Approval Required |